KAIG Consulting Ltd. was established to provide strategic advice in a number of areas:
- Early / translational development, seeking to establish proof of concept, potential profile / value and a firm foundation for later phases in an efficient and effective manner
- Late Phase development, including appropriate global regulatory strategy to identify / minimise risks during later review. Also in this phase, clearly identifying value drivers, and how suitable data can be collected in an integrated manner to also allow dialogue with payers and patients
- Regulatory Licensing, including preparation for submission and through the review and approval phases with FDA, EMA, PMDA and other global Regulatory Agencies
- Business Development support for in and out-licensing of pre- and post approval medicines including technical due diligence